Header Logo

Lauren Dockery

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local
5
2026
348
1.550
 Why?
Ovarian Neoplasms
7
2026
607
1.390
 Why?
Uterine Cervical Neoplasms
2
2022
305
1.040
 Why?
Endometrial Neoplasms
2
2025
189
0.840
 Why?
Vulvar Neoplasms
1
2021
25
0.670
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2020
38
0.670
 Why?
Carcinoma in Situ
1
2021
46
0.660
 Why?
Disease Management
1
2021
91
0.630
 Why?
Platinum Compounds
1
2019
14
0.620
 Why?
Patient Navigation
1
2018
8
0.550
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2022
433
0.550
 Why?
United States Indian Health Service
1
2018
18
0.550
 Why?
Phthalazines
1
2017
25
0.530
 Why?
Piperazines
1
2017
50
0.520
 Why?
Neoplasms, Glandular and Epithelial
1
2017
72
0.510
 Why?
Antineoplastic Agents
1
2019
686
0.410
 Why?
Indians, North American
1
2018
545
0.400
 Why?
Female
11
2026
15740
0.340
 Why?
Bevacizumab
2
2022
106
0.320
 Why?
Aged
6
2026
5627
0.290
 Why?
Molecular Targeted Therapy
2
2020
137
0.290
 Why?
Humans
11
2026
29078
0.250
 Why?
Retrospective Studies
4
2024
2651
0.240
 Why?
Aged, 80 and over
3
2025
2070
0.240
 Why?
Granulosa Cell Tumor
1
2026
4
0.240
 Why?
CD47 Antigen
1
2025
4
0.220
 Why?
CD40 Antigens
1
2025
14
0.220
 Why?
Machine Learning
1
2025
98
0.210
 Why?
Middle Aged
5
2026
7458
0.200
 Why?
Neoadjuvant Therapy
1
2024
80
0.200
 Why?
Prealbumin
1
2022
4
0.190
 Why?
Endometrium
1
2022
39
0.180
 Why?
Cervix Uteri
1
2022
65
0.180
 Why?
Indoles
1
2022
111
0.170
 Why?
Adult
4
2026
8080
0.170
 Why?
Vulvar Lichen Sclerosus
1
2021
1
0.170
 Why?
Vulva
1
2021
5
0.170
 Why?
Indazoles
1
2020
18
0.160
 Why?
Papillomaviridae
1
2021
90
0.160
 Why?
Fallopian Tube Neoplasms
1
2020
53
0.160
 Why?
Piperidines
1
2020
48
0.160
 Why?
Peritoneal Neoplasms
1
2020
80
0.150
 Why?
Disease-Free Survival
1
2019
236
0.150
 Why?
Papillomavirus Infections
1
2021
156
0.150
 Why?
Patient Compliance
1
2018
77
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
26
0.130
 Why?
Disease Progression
1
2019
481
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2017
32
0.130
 Why?
Treatment Outcome
2
2020
2430
0.120
 Why?
Randomized Controlled Trials as Topic
1
2017
413
0.120
 Why?
Age Factors
1
2017
740
0.110
 Why?
Risk Factors
1
2021
2138
0.110
 Why?
Prospective Studies
1
2017
1286
0.100
 Why?
United States
1
2018
2252
0.090
 Why?
Young Adult
1
2018
2855
0.080
 Why?
Adolescent
1
2018
3233
0.080
 Why?
Immunoglobulin Fc Fragments
1
2025
5
0.060
 Why?
Recombinant Fusion Proteins
1
2025
233
0.050
 Why?
Drug Resistance, Neoplasm
1
2025
171
0.050
 Why?
Interleukin-8
1
2022
45
0.050
 Why?
Cytoreduction Surgical Procedures
1
2022
33
0.050
 Why?
Predictive Value of Tests
1
2024
485
0.050
 Why?
Chemotherapy, Adjuvant
1
2022
118
0.050
 Why?
Vitamin D
1
2022
53
0.050
 Why?
Interleukin-6
1
2022
198
0.040
 Why?
Pilot Projects
1
2022
465
0.040
 Why?
Biomarkers
1
2022
787
0.040
 Why?
Prognosis
1
2020
815
0.030
 Why?
Postoperative Complications
1
2022
639
0.030
 Why?
Dockery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (24)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_